Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Ito, Hiroyasu ^a   Seishima, Mitsuru ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; SULFATIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELL ACTIVATION; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NATURAL KILLER T CELL; NONHUMAN; REVIEW; TUMOR IMMUNITY;

ANIMALIA;

EID: 77953533187     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/641757     Document Type: Review

References (76)

1. Yang Y., Xiang Z., Ertl H. C. J., Wilson J. M., Upregulation of class I major histocompatibility complex antigens by interferon is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo Proceedings of the National Academy of Sciences of the United States of America 1995 92 16 7257 7261
2. Mo X. Y., Tripp R. A., Sangster M. Y., Doherty P. C., The cytotoxic T-lymphocyte response to sendai virus is unimpaired in the absence of gamma interferon Journal of Virology 1997 71 3 1906 1910
3. Kawano T., Cui J., Koezuka Y., CD1d-restricted and TCR-mediated activation of V 14 NKT cells by glycosylceramides Science 1997 278 5343 1626 1629
4. Taniguchi M., Seino K. I., Nakayama T., The NKT cell system: bridging innate and acquired immunity Nature Immunology 2003 4 12 1164 1165
5. Kawano T., Cui J., Koezuka Y., Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated V 14 NKT cells Proceedings of the National Academy of Sciences of the United States of America 1998 95 10 5690 5693
6. Nieda M., Nicol A., Koezuka Y., TRAIL expression by activated human CD4+V 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells Blood 2001 97 7 2067 2074
7. Baron J. L., Gardiner L., Nishimura S., Shinkai K., Locksley R., Ganem D., Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection Immunity 2002 16 4 583 594
8. Exley M. A., He Q., Cheng O., Cutting edge: compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver Journal of Immunology 2002 168 4 1519 1523
9. Fuss I. J., Heller F., Boirivant M., Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis Journal of Clinical Investigation 2004 113 10 1490 1497
10. Jahng A., Maricic I., Aguilera C., Cardell S., Halder R. C., Kumar V., Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide Journal of Experimental Medicine 2004 199 7 947 957
11. Terabe M., Swann J., Ambrosino E., A nonclassical non-V 14J 18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance Journal of Experimental Medicine 2005 202 12 1627 1633
12. Ambrosino E., Terabe M., Halder R. C., Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis Journal of Immunology 2007 179 8 5126 5136
13. Takahashi T., Nieda M., Koezuka Y., Analysis of human V 24+ CD 4+ NKT cells activated by -glycosylceramide-pulsed monocyte-derived dendritic cells Journal of Immunology 2000 164 9 4458 4464
14. Metelitsa L. S., Naidenko O. V., Kant A., Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells Journal of Immunology 2001 167 6 3114 3122
15. Cui J., Shin T., Kawano T., Requirement for V 14 NKT cells in IL-12-mediated rejection of tumors Science 1997 278 5343 1623 1626
16. Exley M. A., Bigley N. J., Cheng O., CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus Journal of Leukocyte Biology 2001 69 5 713 718
17. van Dommelen S. L. H., Tabarias H. A., Smyth M. J., Degli-Esposti M. A., Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells Journal of Virology 2003 77 3 1877 1884
18. Johnson T. R., Hong S., Van Kaer L., Koezuka Y., Graham B. S., NK T cells contribute to expansion of CD 8+ T cells and amplification of antiviral immune responses to respiratory syncytial virus Journal of Virology 2002 76 9 4294 4303
19. Ito H., Ando K., Nakayama T., Role of V 14 NKT cells in the development of impaired liver regeneration in vivo Hepatology 2003 38 5 1116 1124
20. Ohtaki H., Ito H., Ando K., V 14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes Biochemical and Biophysical Research Communications 2009 378 3 579 583
21. Shin T., Nakayama T., Akutsu Y., Inhibition of tumor metastasis by adoptive transfer of IL-12-activated V 14 NKT cells International Journal of Cancer 2001 91 4 523 528
22. Ito H., Ando K., Ishikawa T., Role of V 14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of V 14+ NKT cells promotes the breakage of CTL tolerance International Immunology 2008 20 7 869 879
23. Hermans I. F., Silk J. D., Gileadi U., NKT cells enhance CD 4+ and CD 8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells Journal of Immunology 2003 171 10 5140 5147
24. Frankenberger B., Pohla H., Noessner E., Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs Clinical Cancer Research 2005 11 5 1733 1742
25. Hiraoka S.-I., Takeuchi N., Bian Y., B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD 8+ cytotoxic T lymphocyte precursors International Immunology 2005 17 8 1071 1079
26. Bertagnolli M., Herrmann S., IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes: multiple lymphokines required for proliferation and cytotoxicity Journal of Immunology 1990 145 6 1706 1712
27. Chen W.-F., Zlotnik A., IL-10: a novel cytotoxic T cell differentiation factor Journal of Immunology 1991 147 2 528 534
28. Pardoux C., Asselin-Paturel C., Chehimi J., Gay F., Mami-Chouaib F., Chouaib S., Functional interaction between TGF- and IL-12 in human primary allogeneic cytotoxicity and proliferative response Journal of Immunology 1997 158 1 136 143
29. Kanai T., Thomas E. K., Yasutomi Y., Letvin N. L., IL-15 stimulates the expansion of AIDS virus-specific CTL Journal of Immunology 1996 157 8 3681 3687
30. Kasahara S., Ando K., Saito K., Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes Journal of Virology 2003 77 4 2469 2476
31. Gately M. K., Warrier R. R., Honasoge S., Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN- in vivo International Immunology 1994 6 1 157 167
32. Leist T. P., Kohler M., Eppler M., Zinkernagel R. M., Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help Journal of Immunology 1989 143 2 628 632
33. Lin C.-T., Tsai Y.-C., He L., DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity Immunology Letters 2007 114 2 86 93
34. Fukao T., Koyasu S., Expression of functional IL-2 receptors on mature splenic dendritic cells European Journal of Immunology 2000 30 5 1453 1457
35. Gonzalez-Aseguinolaza G., Van Kaer L., Bergmann C. C., Natural killer T cell ligand -galactosylceramide enhances protective immunity induced by malaria vaccines Journal of Experimental Medicine 2002 195 5 617 624
36. Moreno M., Molling J. W., von Mensdorff-Pouilly S., IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses The Journal of Immunology 2008 181 2446 2454
37. Tomura M., Yu W.-G., Ahn H.-J., A novel function of V 14+ CD 4+ NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system Journal of Immunology 1999 163 1 93 101
38. Kitamura H., Iwakabe K., Yahata T., The natural killer T (NKT) cell ligand -galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells Journal of Experimental Medicine 1999 189 7 1121 1128
39. Eberl G., Brawand P., MacDonald H. R., Selective bystander proliferation of memory CD 4+ and CD 8+ T cells upon NK T or T cell activation Journal of Immunology 2000 165 8 4305 4311
40. Fujii S.-I., Shimizu K., Smith C., Bonifaz L., Steinman R. M., Activation of natural killer T cells by -galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein Journal of Experimental Medicine 2003 198 2 267 279
41. Hayakawa Y., Takeda K., Yagita H., Van Kaer L., Saiki I., Okumura K., Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways Journal of Immunology 2001 166 10 6012 6018
42. Vinay D. S., Choi B. K., Bae J. S., Kim W. Y., Gebhardt B. M., Kwon B. S., CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses Journal of Immunology 2004 173 6 4218 4229
43. Kaneda H., Takeda K., Ota T., ICOS costimulates invariant NKT cell activation Biochemical and Biophysical Research Communications 2005 327 1 201 207
44. Marschner A., Rothenfusser S., Hornung V., CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells European Journal of Immunology 2005 35 8 2347 2357
45. Uldrich A. P., Crowe N. Y., Kyparissoudis K., NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, bim-dependent contraction, and hyporesponsiveness to further antigenic challenge Journal of Immunology 2005 175 5 3092 3101
46. Freigang S., Probst H. C., van den Broek M., DC infection promotes antiviral CTL priming: the Winkelried strategy Trends in Immunology 2005 26 1 13 18
47. Ikeda H., Chamoto K., Tsuji T., The critical role of type-1 innate and acquired immunity in tumor immunotherapy Cancer Science 2004 95 9 697 703
48. Ludewig B., Odermatt B., Ochsenbein A. F., Zinkernagel R. M., Hengartner H., Role of dendritic cells in the induction and maintenance of autoimmune diseases Immunological Reviews 1999 169 45 54
49. Smyth M. J., Crowe N. Y., Pellicci D. G., Sequential production of interferon-gamma by NK 1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide Blood 2002 99 4 1259 1266
50. Hayakawa Y., Takeda K., Yagita H., Critical contribution of IFN- and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of -galactosylceramide European Journal of Immunology 2001 31 6 1720 1727
51. Fujii S.-I., Liu K., Smith C., Bonito A. J., Steinman R. M., The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation Journal of Experimental Medicine 2004 199 12 1607 1618
52. Gorelik L., Flavell R. A., Transforming growth factor- in T-cell biology Nature Reviews Immunology 2002 2 1 46 53
53. Letterio J. J., Murine models define the role of TGF- as a master regulator of immune cell function Cytokine and Growth Factor Reviews 2000 11 1-2 81 87
54. Diebold R. J., Eis M. J., Yin M., Early-onset multifocal inflammation in the transforming growth factor 1-null mouse is lymphocyte mediated Proceedings of the National Academy of Sciences of the United States of America 1995 92 26 12215 12219
55. Takaku S., Terabe M., Ambrosino E., Blockade of TGF- enhances tumor vaccine efficacy mediated by CD 8+ T cells International Journal of Cancer 2010 126 7 1666 1674
56. Biburger M., Tiegs G., -galactosylceramide-induced liver injury in mice is mediated by TNF- but independent of Kupffer cells Journal of Immunology 2005 175 3 1540 1550
57. Zhou D., Mattner J., Cantu C. III, Lysosomal glycosphingolipid recognition by NKT cells Science 2004 306 5702 1786 1789
58. Santodomingo-Garzon T., Han J., Le T., Yang Y., Swain M. G., Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice Hepatology 2009 49 4 1267 1276
59. Matsui S., Ahlers J. D., Vortmeyer A. O., A model for CD 8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL Journal of Immunology 1999 163 1 184 193
60. Terabe M., Matsui S., Noben-Trauth N., NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway Nature Immunology 2000 1 6 515 520
61. Terabe M., Matsui S., Park J.-M., Transforming growth factor- production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence Journal of Experimental Medicine 2003 198 11 1741 1752
62. Halder R. C., Aguilera C., Maricic I., Kumar V., Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease Journal of Clinical Investigation 2007 117 8 2302 2312
63. Zeng D., Lewis D., Dejbakhsh-Jones S., Bone marrow NK 1.1- and NK 1.1+ T cells reciprocally regulate acute graft versus host disease Journal of Experimental Medicine 1999 189 7 1073 1081
64. Lan F., Zeng D., Higuchi M., Predominance of NK 1.1+ TCR + or DX 5+ TCR + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus, host disease: Natural suppressor cells Journal of Immunology 2001 167 4 2087 2096
65. Hong S., Wilson M. T., Serizawa I., The natural killer T-cell ligand -galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice Nature Medicine 2001 7 9 1052 1056
66. Beaudoin L., Laloux V. E., Novak J., Lucas B., Lehuen A., NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic cells Immunity 2002 17 6 725 736
67. Alegre M. L., Frauwirth K. A., Thompson C. B., T-cell regulation by CD28 and CTLA-4 Nature Reviews Immunology 2001 1 3 220 228
68. Walunas T. L., Lenschow D. J., Bakker C. Y., CTLA-4 can function as a negative regulator of T cell activation Immunity 1994 1 5 405 413
69. Pilones K. A., Kawashima N., Yang A. M., Babb J. S., Formenti S. C., Demaria S., Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade Clinical Cancer Research 2009 15 2 597 606
70. Keir M. E., Francisco L. M., Sharpe A. H., PD-1 and its ligands in T-cell immunity Current Opinion in Immunology 2007 19 3 309 314
71. Okazaki T., Honjo T., The PD-1-PD-L pathway in immunological tolerance Trends in Immunology 2006 27 4 195 201
72. Martin-Orozco N., Wang Y.-H., Yagita H., Dong C., Cutting edge: programed death (PD) ligand-1/PD-1 interaction is required for CD 8+ T cell tolerance to tissue antigens Journal of Immunology 2006 177 12 8291 8295
73. Parekh V. V., Lalani S., Kim S., PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells Journal of Immunology 2009 182 5 2816 2826
74. Parekh V. V., Wilson M. T., Olivares-Villagomez D., Glycolipid antigen induces long-term natural killer T cell anergy in mice Journal of Clinical Investigation 2005 115 9 2572 2583
75. Chang W.-S., Kim J.-Y., Kim Y.-J., Cutting edge: programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy Journal of Immunology 2008 181 10 6707 6710
76. Akbari O., Stock P., Singh A. K., PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions Mucosal Immunology 2010 3 1 81 91